References

Tube travel: the role of proteases in individual and collective cancer cell invasion

10.1158/0008-5472.can-08-0784 · 2008 · External reference

Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited

10.1083/jcb.200807195 · 2009 · External reference

Bone microenvironment modulates expression and activity of cathepsin B in prostate cancer

10.1593/neo.04349 · 2005 · External reference

Pericellular cathepsin B and malignant progression

10.1023/a:1023007717757 · 2003 · External reference

Immunohistochemical localization of cathepsin B in neoplastic human prostate

10.1002/pros.2990260402 · 1995 · External reference

Lysosomal cathepsin B participates in the podosome-mediated extracellular matrix degradation and invasion via secreted lysosomes in v-Src fibroblasts

10.1158/0008-5472.can-07-5127 · 2008 · External reference

Lysosomal involvement in cell death and cancer

10.1016/j.bbamcr.2008.09.008 · 2009 · External reference

Actin filaments and myosin I alpha cooperate with microtubules for the movement of lysosomes

10.1091/mbc.12.12.4013 · 2001 · External reference

Inhibition of glioma cell lysosome exocytosis inhibits glioma invasion

10.1371/journal.pone.0045910 · 2012 · External reference

Thiazolidinediones induce Rab7-RILP-MAPK-dependent juxtanuclear lysosome aggregation and reduce tumor cell invasion

10.1111/j.1600-0854.2009.01012.x · 2010 · External reference

Supporting a role for the GTPase Rab7 in prostate cancer progression

10.1371/journal.pone.0087882 · 2014 · External reference

Na+/H+ exchangers and RhoA regulate acidic extracellular pH-induced lysosome trafficking in prostate cancer cells

10.1111/j.1600-0854.2009.00904.x · 2009 · External reference

HGF-induced invasion by prostate tumor cells requires anterograde lysosome trafficking and activity of Na+–H+ exchangers

10.1242/jcs.063644 · 2010 · External reference

Extracellular acidification alters lysosomal trafficking in human breast cancer cells

10.1016/s1476-5586(03)80037-4 · 2003 · External reference

MRI of the tumor microenvironment

10.1002/jmri.10181 · 2002 · External reference

Acidic pH enhances the invasive behavior of human melanoma cells

10.1007/bf00121214 · 1996 · External reference

Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice

10.1158/0008-5472.can-06-0983 · 2006 · External reference

SIRT1 regulates Dishevelled proteins and promotes transient and constitutive Wnt signaling

10.1073/pnas.0911325107 · 2010 · External reference

The sirtuins promote Dishevelled-1 scaffolding of TIAM1, Rac activation and cell migration

10.1038/onc.2013.549 · 2013 · External reference

Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase

10.1038/35001622 · 2000 · External reference

Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes

10.1158/0008-5472.can-05-3617 · 2006 · External reference

The Rab7 effector protein RILP controls lysosomal transport by inducing the recruitment of dynein-dynactin motors

10.1016/s0960-9822(01)00531-0 · 2001 · External reference

Phenotypic and cytogenetic characterization of a cell line derived from primary prostatic carcinoma

10.1002/ijc.2910440525 · 1989 · External reference

Knockdown of core binding factorbeta alters sphingolipid metabolism

10.1002/jcp.24406 · 2013 · External reference

Troglitazone induces a cellular acidosis by inhibiting acid extrusion in cultured rat mesangial cells

10.1152/ajpregu.00506.2001 · 2002 · External reference

Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes

10.1074/jbc.m412357200 · 2005 · External reference

SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction

10.1111/j.1474-9726.2007.00304.x · 2007 · External reference

Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage

10.1128/mcb.26.1.28-38.2006 · 2006 · External reference

Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson’s disease

10.1126/science.1143780 · 2007 · External reference

Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1

10.1074/jbc.m205670200 · 2002 · External reference

Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme

10.1016/j.molcel.2005.02.022 · 2005 · External reference

Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A

10.1016/s0021-9258(17)44885-x · 1990 · External reference

Activation of endosomal dynein motors by stepwise assembly of Rab7-RILP-p150Glued, ORP1L, and the receptor betalll spectrin

10.1083/jcb.200606077 · 2007 · External reference

The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product

10.1126/science.1411546 · 1992 · External reference

Active erk regulates microtubule stability in H-ras-transformed cells

10.1038/sj.neo.7900180 · 2001 · External reference

Autophagy: cellular and molecular mechanisms

10.1002/path.2697 · 2010 · External reference

Dynein-dependent movement of autophagosomes mediates efficient encounters with lysosomes

10.1247/csf.08005 · 2008 · External reference

A non-canonical MEK/ERK signaling pathway regulates autophagy via regulating Beclin 1

10.1074/jbc.m109.026013 · 2009 · External reference

LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing

10.1093/emboj/19.21.5720 · 2000 · External reference

Cathepsin B inhibition interferes with metastatic potential of human melanoma: an in vitro and in vivo study

10.1186/1476-4598-9-207 · 2010 · External reference

Inhibition of cathepsin B activity attenuates extracellular matrix degradation and inflammatory breast cancer invasion

10.1186/bcr3058 · 2011 · External reference

Cathepsin B inhibition limits bone metastasis in breast cancer

10.1158/0008-5472.can-11-2759 · 2012 · External reference

Tumour microenvironment-opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy

10.1038/nrc1821 · 2006 · External reference

Acetylation and deacetylation of non-histone proteins

10.1016/j.gene.2005.09.010 · 2005 · External reference

Deacetylation of cortactin by SIRT1 promotes cell migration

10.1038/onc.2008.388 · 2009 · External reference

The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase

10.1016/s1097-2765(03)00038-8 · 2003 · External reference

Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington’s disease by increasing tubulin acetylation

10.1523/jneurosci.0037-07.2007 · 2007 · External reference

The sirtuin inhibitor cambinol impairs MAPK signaling, inhibits inflammatory and innate immune responses and protects from septic shock

10.1016/j.bbamcr.2013.03.004 · 2013 · External reference

SIRT1 promotes N-Myc oncogenesis through a positive feedback loop involving the effects of MKP3 and ERK on N-Myc protein stability

10.1371/journal.pgen.1002135 · 2011 · External reference

The novel lipid raft adaptor p18 controls endosome dynamics by anchoring the MEK–ERK pathway to late endosomes

10.1038/emboj.2008.308 · 2009 · External reference

Trk activation of the ERK1/2 kinase pathway stimulates intermediate chain phosphorylation and recruits cytoplasmic dynein to signaling endosomes for retrograde axonal transport

10.1523/jneurosci.5599-11.2012 · 2012 · External reference

Role of PI3K/Akt/mTOR and MEK/ERK pathway in Concanavalin A induced autophagy in HeLa cells

10.1016/j.cbi.2014.01.003 · 2014 · External reference

ERK and cell death: mechanisms of ERK-induced cell death—apoptosis, autophagy and senescence

10.1111/j.1742-4658.2009.07366.x · 2010 · External reference

New and emerging HDAC inhibitors for cancer treatment

10.1172/jci69738 · 2014 · External reference